The Motley Fool·8h ago·Andy GouldCrescent Grove Cuts Ultrashort Bond Bet as Rate Environment ShiftsCrescent Grove Advisors sold $5.4M stake in ultrashort bond ETF $UYLD, trimming position by 30% amid potential Fed rate-cut signals. UYLDportfolio rebalancingdividend yield
The Motley Fool·1d ago·Jonathan PoncianoClean Energy Believer: Fund Trims $4M Position Despite 84% RallyFlorin Court Capital sold $3.64M of clean energy ETF shares in Q1 2026 after 84% surge, but maintains it as largest holding at 18.5%. ICLNportfolio rebalancingrenewable energy
The Motley Fool·Mar 19·Seena HassounaSpecialist Biotech Fund's $25.8M Spyre Bet Signals Confidence in Preclinical PipelineVR Adviser increased Spyre Therapeutics stake by 1M shares to $120.74M. Stock surged 132% annually, but preclinical risks remain high for retail investors. SYREbiotech investmentmonoclonal antibodies
The Motley Fool·Mar 5·Jonathan PoncianoSophron Capital Trims Grocery REIT Position as $PECO OutperformsSophron Capital sold $7M worth of Phillips Edison shares in Q4, reducing stake from 6.1% to 4.2%, signaling portfolio rebalancing rather than confidence loss. PECOportfolio rebalancingREIT